NEW NEWs!! APRI 'top of the acquisition list" SEEKING ALPHA
from todays sekking alpha article. The pipeline they have is the envy of the biotech world and could certainly put it at the top of the "acquisition wish list" for many drug manufacturers. Last year and this year mark game-changing years in which many blockbuster drugs began to lose their patents including Cozaar/Hyzaar, Lipitor, Flomax, Arimidex, Climara, Aricept, Hycamtin, Levaquin and a host of others. For those companies with a host of drugs in their pipelines, their own new drugs coming along can offset the revenue lost due to competition by generics. However, for many companies the regulatory approval process hasn’t been particularly friendly. They will be scrambling for answers, and that can be where Apricus Biosciences can be a good fit to shore up their pipelines and dwindling revenues.
Big Pharma wants it, but I think Dr. Bassam will not give it up ... And if they do Big Pharma will have to buy it for a premium 15.00 + especialy once PREVonco phase 3 data looks positive..
We know they are in talks right now with a Top 5 Pharma company about what I'm not sure Partner/ License/ ...but I can almost Guarentee you a few Pharma companies are looking at APRI right now as a buyout possibilty.. and I'm sure some type of discussions have happened becuase the APRI pipeline is very deep and holds alot of promise......